Mode
Text Size
Log in / Sign up

Alloplastic TMJ replacement shows low revision risk: 1.41 revisions per 100 joint-yearsNew data shows low revision rates for jaw joint replacements

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider alloplastic TMJR for end-stage TMJ disease; revision risk is low but requires standardized follow-up.

This meta-analysis pooled data from 57 studies comprising 2,816 subjects (4,370 joints) who underwent alloplastic temporomandibular joint replacement (TMJR) with Stryker/TMJ Concepts or Zimmer Biomet prostheses. The primary outcome was revision rate, calculated as revisions per joint-years. The overall risk of revision was 1.41 per 100 joint-years (95% CI: 1.10 to 2.15), with 130 revisions (4.6%) reported. The median follow-up was 2.6 years (interquartile range 2.4).

Among the reasons for revision, infection was the most common, occurring in 51 patients (1.7%), followed by heterotopic bone formation in 38 patients (1.3%). These findings suggest that while complications occur, the overall revision risk is low.

The authors noted moderate heterogeneity (I² = 63%) across studies, attributed to variations in demographics, surgical techniques, and follow-up durations. This heterogeneity limits the precision of the pooled estimate and underscores the need for standardized follow-up protocols in future research.

In practice, these results support the continued use of alloplastic TMJR for end-stage TMJ disease, given the low revision risk. However, the meta-analysis provides an estimate based on existing literature; individual patient outcomes cannot be predicted. Clinicians should weigh these findings when considering surgical options and emphasize the importance of long-term surveillance.

Living with advanced jaw joint disease can be painful and limiting. For those facing surgery to replace the joint with an artificial one, knowing what to expect from the procedure is vital. New data looking at over 2,800 patients shows that these replacements generally hold up well over time.

The analysis looked at thousands of joints across dozens of studies. It found a low overall risk of needing a revision surgery, which is an operation to fix or replace a previous implant. Most issues were caused by things like infection or the growth of extra bone in the wrong place.

While these results are encouraging for people with end-stage jaw disease, keep in mind that every patient is different. Because surgical techniques and patient backgrounds vary, this data provides a general look at risks rather than a specific prediction for any one person. Talk to your doctor about how these findings apply to your specific case.

What this means for you:
Jaw joint replacements have a low risk of needing revision surgery, though infection and bone growth are known risks.

Common questions

How often do jaw joint replacements need to be fixed?

The study found a low overall risk of revision, which is a surgery to fix an implant. The data showed about 1.41 revisions per 100 joint-years. This means that for most patients, the initial replacement remains successful and does not require further operations.

What are the common reasons for revision surgery?

When a revision is necessary, it is often due to specific complications. The study identified infection as a cause in 51 patients (1.7%) and the formation of extra bone in the wrong place, known as heterotopic bone formation, in 38 patients (1.3%).

Is this surgery safe for people with advanced jaw disease?

The findings support the use of artificial joints for end-stage jaw disease because of the low revision rates. However, since every patient's health and surgical experience is unique, you should discuss these specific risks and your personal treatment plan with your doctor.

Study Details

Study typeMeta analysis
Sample sizen = 51
EvidenceLevel 1
Follow-up31.2 mo
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Alloplastic temporomandibular joint replacement (TMJR) is a reliable option for end-stage temporomandibular joint (TMJ) disease, yet revision surgery may still be required for infection, loosening, or heterotopic ossification. As each surgical intervention adds exponentially to the risk of facial nerve injury, assessing risk of revision is essential for surgical planning and patient counseling. PURPOSE: The study purpose was to estimate the revision rate in alloplastic TMJR over time and identify factors associated with revision surgery. DATA SOURCES: A comprehensive search was performed of PubMed, Embase, and the Cochrane Library databases (September 2024). STUDY SELECTION: Eligible studies (published 1990-2024) included more than 5 subjects, reporting revision rates for Stryker/TMJ concepts or Zimmer Biomet prostheses. DATA EXTRACTION AND SYNTHESIS: Data were extracted per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, including revisions, cohort size, mean follow-up time, and reason for revision surgery. Incidence rate meta-analysis was performed using a random-effects model. Robustness of the meta-analysis was evaluated by a leave-one-out analysis. Kaplan-Meier survival analysis assessed time-to-event data. Meta-regression explored confounding factors like publication year and mean patient age. MAIN OUTCOMES AND MEASURES: The primary outcome was revision rate, measured as revisions per joint years (revisions/number of joints × mean follow-up). RESULTS: 57 studies (2,816 subjects, 4,370 joints) were included with 130 (4.6%) revisions and a median follow-up of 2.6 years (interquartile range 2.4) across studies. Meta-analysis revealed an overall risk of revision of 1.41 revisions per 100 joint-years (95% CI: 1.10 to 2.15). Infection (51 patients, 1.7%) and heterotopic bone formation (38 patients, 1.3%) were primary reasons for revision. Moderate heterogeneity (I= 63%) was attributed to variations in demographics, surgical techniques, and follow-up. CONCLUSIONS AND RELEVANCE: TMJR showed a low overall risk of revision with 1.41 revisions per 100 joint-years in the published literature, suggesting that modern TMJR systems offer improved safety and durability with declining complication rates. These findings support the continued use of TMJR for management of end-stage TMJ disease, but also emphasize the need for standardized follow-up and registry-based surveillance.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.